KIT and leukemia: Consistent with the transcriptome analysis, in the Cxcr4-disrupted leukemia cells, we observed a significant increase in ROS in both the LSCs (c-Kit+) and the bulk leukemia cells in vivo (Figure 5A; Figure S5B–S5D).